CDKN1B and neuroendocrine neoplasm: Cases associated with CDKN1B mutations display a heterogeneous phenotype, referred to as MEN4, encompassing parathyroid and pituitary adenomas, neuroendocrine tumors and various benign and malignant tumors (Pellegata et al. 2006).